wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33407672-D0F17D20-AB29-438F-80D8-1468070CC580
Q33407672-D0F17D20-AB29-438F-80D8-1468070CC580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33407672-D0F17D20-AB29-438F-80D8-1468070CC580
A phase I trial of bortezomib in combination with epirubicin, carboplatin and capecitabine (ECarboX) in advanced oesophagogastric adenocarcinoma.
P2860
Q33407672-D0F17D20-AB29-438F-80D8-1468070CC580
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33407672-D0F17D20-AB29-438F-80D8-1468070CC580
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
faa38573abc7e6c0061be4b502611f6a828a913e
P2860
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma.